267 related articles for article (PubMed ID: 20530676)
21. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
[TBL] [Abstract][Full Text] [Related]
22. Regulation of K562 cell transferrin receptors by exogenous iron.
Rudolph NS; Ohlsson-Wilhelm BM; Leary JF; Rowley PT
J Cell Physiol; 1985 Mar; 122(3):441-50. PubMed ID: 2981898
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
24. The effect of anti-TfR mouse/human chimeric antibody on anti-transplant rejection.
Ye Q; Wang Z; Li Y; Wang S; Zhou H; Zhu H; Lei P; Liu L; Shen G
Transpl Int; 2011 Feb; 24(2):167-74. PubMed ID: 20840666
[TBL] [Abstract][Full Text] [Related]
25. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
Recht LD; Griffin TW; Raso V; Salimi AR
Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of heme synthesis decreases transferrin receptor expression in mouse erythroleukemia cells.
Hradilek A; Fuchs O; Neuwirt J
J Cell Physiol; 1992 Feb; 150(2):327-33. PubMed ID: 1734036
[TBL] [Abstract][Full Text] [Related]
27. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
28. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
[TBL] [Abstract][Full Text] [Related]
29. Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.
Amoroso AR; Clark JI; Litwin S; Hsieh-Ma S; Shi T; Alpaugh RK; Adams GP; Wolf EJ; Ring DB; Weiner LM
Cancer Res; 1996 Jan; 56(1):113-20. PubMed ID: 8548750
[TBL] [Abstract][Full Text] [Related]
30. Target structure for natural killer cells: evidence against a unique role for transferrin receptor.
Dokhélar MC; Garson D; Testa U; Tursz T
Eur J Immunol; 1984 Apr; 14(4):340-4. PubMed ID: 6327320
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of transferrin receptor surface expression by intracellular antibody.
Peng JL; Wu S; Zhao XP; Wang M; Li WH; Shen X; Liu J; Lei P; Zhu HF; Shen GX
Biochem Biophys Res Commun; 2007 Mar; 354(4):864-71. PubMed ID: 17266924
[TBL] [Abstract][Full Text] [Related]
32. Antigen entry into early endosomes is insufficient for MHC class II processing.
Niebling WL; Pierce SK
J Immunol; 1993 Apr; 150(7):2687-97. PubMed ID: 8384229
[TBL] [Abstract][Full Text] [Related]
33. Entamoeba histolytica: transferrin binding proteins.
Reyes-López M; Serrano-Luna JJ; Negrete-Abascal E; León-Sicairos N; Guerrero-Barrera AL; de la Garza M
Exp Parasitol; 2001 Nov; 99(3):132-40. PubMed ID: 11846523
[TBL] [Abstract][Full Text] [Related]
34. Single particle reconstruction of the human apo-transferrin-transferrin receptor complex.
Cheng Y; Zak O; Aisen P; Harrison SC; Walz T
J Struct Biol; 2005 Dec; 152(3):204-10. PubMed ID: 16343946
[TBL] [Abstract][Full Text] [Related]
35. Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.
Brooks D; Taylor C; Dos Santos B; Linden H; Houghton A; Hecht TT; Kornfeld S; Taetle R
Clin Cancer Res; 1995 Nov; 1(11):1259-65. PubMed ID: 9815920
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody.
Callens C; Moura IC; Lepelletier Y; Coulon S; Renand A; Dussiot M; Ghez D; Benhamou M; Monteiro RC; Bazarbachi A; Hermine O
Leukemia; 2008 Jan; 22(1):42-8. PubMed ID: 17898788
[TBL] [Abstract][Full Text] [Related]
37. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
[TBL] [Abstract][Full Text] [Related]
38. Receptor-mediated endocytosis of human transferrin and its cell surface receptor.
Larrick JW; Enns C; Raubitschek A; Weintraub H
J Cell Physiol; 1985 Aug; 124(2):283-7. PubMed ID: 2995416
[TBL] [Abstract][Full Text] [Related]
39. Immunological study of complex formation between soluble transferrin receptor and transferrin.
Kogan A; Filatov V; Gusev N; Bereznikova A; Kolosova O; Katrukha A
Am J Hematol; 2005 Aug; 79(4):281-7. PubMed ID: 16044455
[TBL] [Abstract][Full Text] [Related]
40. A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.
Neiveyans M; Melhem R; Arnoult C; Bourquard T; Jarlier M; Busson M; Laroche A; Cerutti M; Pugnière M; Ternant D; Gaborit N; Chardès T; Poupon A; Gouilleux-Gruart V; Pèlegrin A; Poul MA
MAbs; 2019 Apr; 11(3):593-605. PubMed ID: 30604643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
